Target intelligence / Profile preview

Novel transcript, antisense to Ring Finger Protein 138 (None established; ENSG00000265008 is a genome annotation ID)

Target
None established; ENSG00000265008 is a genome annotation ID
Molecular classification
Non-coding RNA, Antisense RNA, Other (not a receptor, enzyme, transporter, or transcription factor)
01

Overview

The "novel transcript, antisense to RNF138" (ENSG00000265008) is an annotated non-coding RNA transcribed antisense to the RNF138 gene. Antisense non-coding RNAs are widely distributed in genomes and can regulate the corresponding sense transcript by modifying chromatin state, transcription rates, and mRNA processing, typically through mechanisms involving interference or epigenetic modulation[2][4]. No experimental data are available to link this particular transcript to a defined biological or pathological process, nor to any existing drug, biomarker, or safety concern. Unlike the protein-coding RNF138 gene (an E3 ubiquitin ligase involved in DNA double-strand break repair[5]), the antisense transcript lacks an open reading frame and is not known to encode any functional protein. This transcript may reflect a general phenomenon of antisense regulation, where such RNAs alter the chromatin environment or stability of paired sense mRNAs, but no specific functional or disease-related data exist for ENSG00000265008 itself[2][4].

Other names
ENSG00000265008 (Ensembl gene ID)Novel antisense transcript to RNF138
02

Mechanism of action

None known. Antisense non-coding RNAs principally act via regulation of sense transcript production and processing, chromatin modification, and mRNA stability.

03

Biological functions

Transcriptional regulation (via antisense effects on RNF138 expression, as antisense RNAs broadly can influence chromatin dynamics and gene transcription rates)Other (no direct evidence for functions beyond regulatory potential)
04

Disease associations

Other (no established or direct association with diseases; the RNF138 sense gene is implicated in DNA repair and episodic ataxia[5], but the antisense transcript itself has no documented disease role)
05

Safety considerations

None known. No demonstrated therapeutic manipulation or clinical relevance.
06

Interacting drugs

None known.
07

Biomarkers

None known.

Beyond the preview

Go deeper on Novel transcript, antisense to Ring Finger Protein 138 (None established; ENSG00000265008 is a genome annotation ID).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to Ring Finger Protein 138 (None established; ENSG00000265008 is a genome annotation ID).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call